Howard Liang, CFO & Chief Strategy Officer at BeiGene, Ltd. (BGNE), sold 44,933 shares at $195.57 ($8.7M) on 2019-11-18, disclosed to the SEC on 2019-11-20.
Open-market sale of $8.7M BGNE by CFO & Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $191.80 | 1,156 | $222K | 2.5% |
| 2 | $192.63 | 2,311 | $445K | 5.1% |
| 3 | $193.60 | 6,944 | $1.3M | 15.4% |
| 4 | $193.60 | 6,944 | $1.3M | 15.4% |
| 5 | $194.62 | 8,156 | $1.6M | 18.2% |
| 6 | $194.62 | 8,156 |
| $1.6M |
| 18.2% |
| 7 | $195.57 | 5,633 | $1.1M | 12.6% |
| 8 | $195.57 | 5,633 | $1.1M | 12.6% |
| Total | $194.37 avg | 44,933 | $8.7M | 100% |
| Filing → |
| BGNE | SELL | 2021-06-09 | $460K | — | Filing → |
| BGNE | SELL | 2021-01-19 | $9.6M | — | Filing → |
| BGNE | SELL | 2020-12-16 | $39.2M | — | Filing → |